Zobrazeno 1 - 10
of 154
pro vyhledávání: '"H R, Roberts"'
Publikováno v:
Aesthetic Surgery Journal Open Forum, Vol 6 (2023)
Abstract The importance of written communication between clinicians and patients, especially in the wake of the Supreme Court case of Montgomery vs Lanarkshire, has led to a shift toward patient-centric care in the United Kingdom. This study investi
Externí odkaz:
https://doaj.org/article/ea32a36da431460eaa012ae5f09358d3
Autor:
H. R. Roberts, Liselotte S. Ebbesen, Rolf Ljung, Barbara A. Konkle, W. K. Hoots, G. Auerswald, James Weatherall, J.-M. Ferran
Publikováno v:
Haemophilia. 14:466-475
Haemophilia patients with inhibitors characteristically have impaired joint function and reduced health-related quality of life (HRQoL). This analysis examined whether secondary prophylaxis with recombinant activated factor VII (rFVIIa) improves HRQo
Autor:
H. R. Roberts, J. Brock, Maureane Hoffman, Mirella Ezban, Dougald M. Monroe, Ulla Hedner, Anna G. McDonald
Publikováno v:
Journal of Thrombosis and Haemostasis. 5:P-T
Autor:
H. R. Roberts
Publikováno v:
Cellular and Molecular Life Sciences. 64:517-521
A classification scheme for patients with hemophilia B has been devised. Assessment of factor IX antigen and factor IX coagulant activity has confirmed the genetic heterogeneity of hemophilia B and has shown that some affected patients have normal am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::275ed05df42756e8f3a0a5e095a98f29
https://doi.org/10.1159/000402152
https://doi.org/10.1159/000402152
Autor:
Craig H. Selzman, Renyi Zhao, George A. Stouffer, Brett C. Sheridan, Alokkumar Pathak, Dougald M. Monroe, H. R. Roberts
Publikováno v:
Journal of Thrombosis and Haemostasis. 4:60-67
Summary. Background: Classically, it is thought that the vast majority of thrombin is generated on the surface of platelets, however, thrombotic events occur in patients despite treatment with potent antiplatelet agents. Methods and results: In fresh
Publikováno v:
Haemophilia. 7:517-522
Inhibitor development is a serious complication in patients with haemophilia A and B. Historically, a lack of optimal therapies and factor products for treating inhibitor patients resulted in many patients developing chronic haemophilic arthropathies
Autor:
P. M. Mannucci, H. R. Roberts
Publikováno v:
Journal of Thrombosis and Haemostasis. 5:445-447
Autor:
H. R. Roberts, H. Smith, Y. Laurian, G. Davignon, Carol K. Kasper, A. Shapiro, J. H. Joist, P. M. Mannucci, Jeanne M. Lusher
Publikováno v:
Haemophilia. 4:790-798
Recombinant factor VIIa (rFVIIa) was developed to provide an improved procoagulant component capable of 'by-passing' inhibitor antibodies in the treatment of haemophilic patients. The primary objective of this study was to compare the efficacy of two
Autor:
C. A. Lee, C. M. Kessler, D. Varon, U. Martinowitz, M. Heim, H. R. ROBERTS, D. M. MONROE, J. A. OLIVER, J.-Y. CHANG, M. HOFFMAN
Publikováno v:
Haemophilia. 4:331-334
Summary. In this report we describe an in vitro model of blood coagulation reactions that mimics as closely as possible the in vivo condition. Our model indicates that the tissue factor—factor VIIa complex initiates coagulation by activating small